Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2026-03-16 @ 3:57 PM
Study NCT ID:
NCT01423604
Status:
COMPLETED
Last Update Posted:
2018-02-12
First Post:
2011-08-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Ruxolitinib in Pancreatic Cancer Patients
Sponsor:
Incyte Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
18424-262
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None